MOJA, PASQUALE LORENZO
MOJA, PASQUALE LORENZO
Risk of severe cardiotoxicity following treatment with trastuzumab: a meta-analysis of randomized and cohort studies of 29,000 women with breast cancer
2016 S. Mantarro; M. Rossi; M. Bonifazi; R. D’Amico; C. Blandizzi; C. La Vecchia; E. Negri; L. Moja
Trastuzumab for HER2+ metastatic breast cancer in clinical practice : cardiotoxicity and overall survival
2016 M. Rossi; G. Carioli; M. Bonifazi; A. Zambelli; M. Franchi; L. Moja; A. Zambon; G. Corrao; C. La Vecchia; C. Zocchetti; E. Negri
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults
2015 Banzi, Rita; Cusi, Cristina; Randazzo, Concetta; Sterzi, Roberto; Tedesco, Dario; Moja, Lorenzo
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults
2015 Banzi, Rita*; Cusi, Cristina; Randazzo, Concetta; Sterzi, Roberto; Tedesco, Dario; Moja, Lorenzo
Effectiveness of trastuzumab in first-line her2+ metastatic breast cancer after failure in adjuvant setting: a controlled cohort study
2014 E. Negri; A. Zambelli; M. Franchi; M. Rossi; M. Bonifazi; G. Corrao; L. Moja; C. Zocchetti; C. La Vecchia
Long term survival of HER2-positive early breast cancer treated with trastuzumab-based adjuvant regimen: a large cohort study from clinical practice
2014 M. Bonifazi; M. Franchi; M. Rossi; A. Zambelli; L. Moja; A. Zambon; G. Corrao; C. La Vecchia; C. Zocchetti; E. Negri
Bevacizumab in clinical practice : prescribing appropriateness relative to national indications and safety
2012 M. Bonifazi; M. Rossi; P.L. Moja; V. D. Scigliano; M. Franchi; C. La Vecchia; C. Zocchetti; E. Negri